These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31970858)

  • 41. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of life measures in dysplastic Barrett's oesophagus are comparable to patients with non-dysplastic Barrett's oesophagus and do not improve after endoscopic therapy.
    Ratcliffe E; Britton J; Heal C; Keld R; Murgatroyd M; Willert R; McLaughlin J; Hamdy S; Ang Y
    BMJ Open Gastroenterol; 2023 Apr; 10(1):. PubMed ID: 37041020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Presence or absence of intestinal metaplasia but not its burden is associated with prevalent high-grade dysplasia and cancer in Barrett's esophagus.
    Bansal A; McGregor DH; Anand O; Singh M; Rao D; Cherian R; Wani SB; Rastogi A; Singh V; House J; Jones PG; Sharma P
    Dis Esophagus; 2014; 27(8):751-6. PubMed ID: 24165297
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patterns of recurrent and persistent intestinal metaplasia after successful radiofrequency ablation of Barrett's esophagus.
    Korst RJ; Santana-Joseph S; Rutledge JR; Antler A; Bethala V; DeLillo A; Kutner D; Lee BE; Pazwash H; Pittman RH; Rahmin M; Rubinoff M
    J Thorac Cardiovasc Surg; 2013 Jun; 145(6):1529-34. PubMed ID: 23219501
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus.
    Kastelein F; Biermann K; Steyerberg EW; Verheij J; Kalisvaart M; Looijenga LH; Stoop HA; Walter L; Kuipers EJ; Spaander MC; Bruno MJ;
    Gut; 2013 Dec; 62(12):1676-83. PubMed ID: 23256952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Standard endoscopy with random biopsies versus narrow band imaging targeted biopsies in Barrett's oesophagus: a prospective, international, randomised controlled trial.
    Sharma P; Hawes RH; Bansal A; Gupta N; Curvers W; Rastogi A; Singh M; Hall M; Mathur SC; Wani SB; Hoffman B; Gaddam S; Fockens P; Bergman JJ
    Gut; 2013 Jan; 62(1):15-21. PubMed ID: 22315471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Endoscopic treatment of Barrett's oesophagus].
    Boyer J
    Ann Chir; 2006 Jan; 131(1):7-11. PubMed ID: 16376846
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Radiofrequency ablation for long- and ultralong-segment Barrett's esophagus: a comparative long-term follow-up study.
    Dulai PS; Pohl H; Levenick JM; Gordon SR; MacKenzie TA; Rothstein RI
    Gastrointest Endosc; 2013 Apr; 77(4):534-41. PubMed ID: 23290719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrence of subsquamous dysplasia and carcinoma after successful endoscopic and radiofrequency ablation therapy for dysplastic Barrett's esophagus.
    Lee JK; Cameron RG; Binmoeller KF; Shah JN; Shergill A; Garcia-Kennedy R; Bhat YM
    Endoscopy; 2013 Jul; 45(7):571-4. PubMed ID: 23592390
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoxia-inducible factor-1α mediates reflux-induced epithelial-mesenchymal plasticity in Barrett's oesophagus patients.
    Zhang Q; Dunbar KB; Odze RD; Agoston AT; Wang X; Su T; Nguyen AD; Zhang X; Spechler SJ; Souza RF
    Gut; 2024 Jul; 73(8):1269-1279. PubMed ID: 38641363
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Is Barrett's metaplasia the source of adenocarcinomas of the cardia?
    Clark GW; Smyrk TC; Burdiles P; Hoeft SF; Peters JH; Kiyabu M; Hinder RA; Bremner CG; DeMeester TR
    Arch Surg; 1994 Jun; 129(6):609-14. PubMed ID: 8204035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Two-stage treatment of Barrett's esophagus].
    Puchkov KV; Khabarova EV; Tishchenko ES
    Khirurgiia (Mosk); 2019; (9):18-24. PubMed ID: 31532162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review and meta-analysis of the effectiveness of radiofrequency ablation in low grade dysplastic Barrett's esophagus.
    Pandey G; Mulla M; Lewis WG; Foliaki A; Chan DSY
    Endoscopy; 2018 Oct; 50(10):953-960. PubMed ID: 29689573
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term recurrence of neoplasia and Barrett's epithelium after complete endoscopic resection.
    Anders M; Bähr C; El-Masry MA; Marx AH; Koch M; Seewald S; Schachschal G; Adler A; Soehendra N; Izbicki J; Neuhaus P; Pohl H; Rösch T
    Gut; 2014 Oct; 63(10):1535-43. PubMed ID: 24389236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Timeline and location of recurrence following successful ablation in Barrett's oesophagus: an international multicentre study.
    Sami SS; Ravindran A; Kahn A; Snyder D; Santiago J; Ortiz-Fernandez-Sordo J; Tan WK; Dierkhising RA; Crook JE; Heckman MG; Johnson ML; Lansing R; Ragunath K; di Pietro M; Wolfsen H; Ramirez F; Fleischer D; Wang KK; Leggett CL; Katzka DA; Iyer PG
    Gut; 2019 Aug; 68(8):1379-1385. PubMed ID: 30635408
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Significance of Nissen fundoplication after endoscopic radiofrequency ablation of Barrett's esophagus.
    Skrobić O; Simić A; Radovanović N; Ivanović N; Micev M; Peško P
    Surg Endosc; 2016 Sep; 30(9):3802-7. PubMed ID: 26659238
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Esophageal motility and impedance characteristics in patients with Barrett's esophagus before and after radiofrequency ablation.
    Hemmink GJ; Alvarez Herrero L; Bogte A; Bredenoord AJ; Bergman JJ; Smout AJ; Weusten BL
    Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1024-32. PubMed ID: 23708277
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
    Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Barrett's esophagus can and does regress after antireflux surgery: a study of prevalence and predictive features.
    Gurski RR; Peters JH; Hagen JA; DeMeester SR; Bremner CG; Chandrasoma PT; DeMeester TR
    J Am Coll Surg; 2003 May; 196(5):706-12; discussion 712-3. PubMed ID: 12742201
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results.
    Van Laethem JL; Cremer M; Peny MO; Delhaye M; Devière J
    Gut; 1998 Dec; 43(6):747-51. PubMed ID: 9824599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.